4//SEC Filing
SAENGER BRADLEY 4
Accession 0001839882-23-004703
CIK 0001430306other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:37 PM ET
Size
7.8 KB
Accession
0001839882-23-004703
Insider Transaction Report
Form 4
SAENGER BRADLEY
Chief Financial Officer
Transactions
- Award
Stock Option
2023-02-23+200,000→ 200,000 totalExercise: $0.91From: 2024-02-23Exp: 2033-02-23→ Common Stock (200,000 underlying) - Award
Stock Option
2023-02-23+200,000→ 200,000 totalExercise: $0.73From: 2024-02-23Exp: 2033-02-23→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001668150
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:37 PM ET
- Size
- 7.8 KB